GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex

The androgen receptor (AR) is a key driver of prostate cancer (PC), even in the state of castration-resistant PC (CRPC) and frequently even after treatment with second-line hormonal therapies such as abiraterone and enzalutamide. The persistence of AR activity via both ligand-dependent and ligand-in...

詳細記述

保存先:
書誌詳細
出版年:Proc Natl Acad Sci U S A
主要な著者: He, Bin, Lanz, Rainer B., Fiskus, Warren, Geng, Chuandong, Yi, Ping, Hartig, Sean M., Rajapakshe, Kimal, Shou, John, Wei, Liping, Shah, Shrijal S., Foley, Christopher, Chew, Sue Anne, Eedunuri, Vijay K., Bedoya, Diego J., Feng, Qin, Minami, Takashi, Mitsiades, Constantine S., Frolov, Anna, Weigel, Nancy L., Hilsenbeck, Susan G., Rosen, Daniel G., Palzkill, Timothy, Ittmann, Michael M., Song, Yongcheng, Coarfa, Cristian, O’Malley, Bert W., Mitsiades, Nicholas
フォーマット: Artigo
言語:Inglês
出版事項: National Academy of Sciences 2014
主題:
Biological Sciences
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4280633/
https://ncbi.nlm.nih.gov/pubmed/25489091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1421415111
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料